SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001367644-13-000016
Filing Date
2013-03-08
Accepted
2013-03-08 13:42:52
Documents
19
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1812567
2 exhibit10-5.htm EX-10.5 19874
3 exhibit10-6.htm EX-10.6 22159
4 exhibit10-7.htm EX-10 10802
5 exhibit10-8.htm EX-10.8 11893
6 exhibit10-1.htm EX-10.1 16670
7 exhibit12.htm EX-12 40104
8 exhibit21.htm EX-21 11137
9 exhibit23-1.htm EX-23.1 5954
10 exhibit31-1.htm EX-31 8955
11 exhibit31-2.htm EX-31.2 8924
12 exhibit32-1.htm EX-32.1 3125
13 exhibit32-2.htm EX-32.2 3112
  Complete submission text file 0001367644-13-000016.txt   10862502

Data Files

Seq Description Document Type Size
14 ebs-20121231.xml EX-101.INS 1596161
15 ebs-20121231.xsd EX-101.SCH 55801
16 ebs-20121231_cal.xml EX-101.CAL 81175
17 ebs-20121231_def.xml EX-101.DEF 331793
18 ebs-20121231_lab.xml EX-101.LAB 953738
19 ebs-20121231_pre.xml EX-101.PRE 572952
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33137 | Film No.: 13676389
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences